Drugplain

Cefotaxime 500 mg/1

Cefotaxime · INJECTION, POWDER, FOR SOLUTION · Hikma Pharmaceuticals USA Inc.

No Recall HistoryCurrently in Shortage
Plain English

Cefotaxime is a injection, powder, for solution containing cefotaxime at 500 mg/1, taken intramuscular. Manufactured by Hikma Pharmaceuticals USA Inc..

Key Facts

Brand Name
Cefotaxime
Generic Name
Cefotaxime
NDC Code (Product)
0143-9930
Manufacturer
Hikma Pharmaceuticals USA Inc.
Strength
500 mg/1
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Marketing Status
Application #
ANDA065072
Marketing Start
11/20/2002

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective363 reports
off label use327 reports
pyrexia279 reports
drug reaction with eosinophilia and systemic symptoms241 reports
acute kidney injury193 reports
thrombocytopenia149 reports
neutropenia147 reports
condition aggravated135 reports
sepsis128 reports
toxic epidermal necrolysis127 reports

Full Prescribing Information

Full prescribing information not available for this product.

Frequently Asked Questions

What is Cefotaxime used for?

Cefotaxime contains Cefotaxime. It is a injection, powder, for solution taken intramuscular. Consult your doctor for specific uses.

Is Cefotaxime a controlled substance?

Cefotaxime is not classified as a controlled substance by the DEA.

What is the generic name for Cefotaxime?

The generic name for Cefotaxime is Cefotaxime. There are no other listed brand versions of Cefotaxime.

What is the NDC code for Cefotaxime 500 mg/1?

The NDC (National Drug Code) for Cefotaxime 500 mg/1 is 0143-9930, listed by Hikma Pharmaceuticals USA Inc..

Product NDC

0143-9930

Package NDC

0143-9930-10

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)